These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6174215)

  • 1. Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T 1/2 clone 8 and V79 cells.
    Landolph JR; Jones PA
    Cancer Res; 1982 Mar; 42(3):817-23. PubMed ID: 6174215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles.
    Patierno SR; Banh D; Landolph JR
    Cancer Res; 1988 Sep; 48(18):5280-8. PubMed ID: 3409252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of Chinese Hamster V79 cells and transformation and mutation of mouse fibroblast C3H/10T1/2 clone 8 cells by aflatoxin B1 and four other furocoumarins isolated from two Nigerian medicinal plants.
    Uwaifo AO; Billings PC; Heidelberger C
    Cancer Res; 1983 Mar; 43(3):1054-8. PubMed ID: 6402296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
    Lee T; Karon M; Monparler RL
    Cancer Res; 1975 Sep; 35(9):2506-10. PubMed ID: 50132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of assay systems for drug-resistant mutation in cultured mammalian cells.
    Ochi T; Umeda M
    Jpn J Exp Med; 1981 Jun; 51(3):141-7. PubMed ID: 7300029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic transformation and mutation of C3H/10T 1/2 clone 8 mouse embryo fibroblasts by alkylating agents.
    Peterson AR; Landolph JR; Peterson H; Spears CP; Heidelberger C
    Cancer Res; 1981 Aug; 41(8):3095-9. PubMed ID: 7248967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells.
    Patierno SR; Lehman NL; Henderson BE; Landolph JR
    Cancer Res; 1989 Feb; 49(4):1038-44. PubMed ID: 2912548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of praziquantel, a new antischistosomal drug, on the mutation and transformation of mammalian cells.
    Billings PC; Heidelberger C
    Cancer Res; 1982 Jul; 42(7):2692-6. PubMed ID: 7083161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of chemically induced multistep neoplastic transformation in C3H 10T 1/2 cells.
    Landolph JR
    Carcinog Compr Surv; 1985; 10():211-23. PubMed ID: 4064004
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine.
    Neil GL; Berger AE; Bhuyan BK; DeSante DC
    Cancer Res; 1976 Mar; 36(3):1114-20. PubMed ID: 56229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further examination of the effects of nitrosylation on Alternaria alternata mycotoxin mutagenicity in vitro.
    Schrader TJ; Cherry W; Soper K; Langlois I
    Mutat Res; 2006 Jul; 606(1-2):61-71. PubMed ID: 16698312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis in Chinese hamster cells by cyclopenta(a)phenanthrenes activated by a human hepatoma cell line.
    Bhatt TS; Coombs M; DiGiovanni J; Diamond L
    Cancer Res; 1983 Mar; 43(3):984-96. PubMed ID: 6297728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic and antimutagenic effects of 5-substituted 2'-deoxyuridines depending on the nature of the 5-substituent.
    Marquardt H; Westendorf J; Schaefer A; Boldt J; De Clercq E; Marquardt H
    Arzneimittelforschung; 1988 Dec; 38(12):1820-4. PubMed ID: 3072958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
    Presant CA; Vietti T; Valeriote F
    Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
    Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
    Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronuclei induced by modulators of methylation: analogs of 5-azacytidine.
    Stopper H; Körber C; Gibis P; Spencer DL; Caspary WJ
    Carcinogenesis; 1995 Jul; 16(7):1647-50. PubMed ID: 7542178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides.
    Jones PA; Benedict WF; Baker MS; Mondal S; Rapp U; Heidelberger C
    Cancer Res; 1976 Jan; 36(1):101-7. PubMed ID: 129280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Takeda K; Suzuki E; Okada M
    IARC Sci Publ; 1984; (57):715-9. PubMed ID: 6398304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in differentiation and pyrimidine pathway enzymes in 5-azacytidine resistant variants of a myoblast line.
    Ng SK; Rogers J; Sanwal BD
    J Cell Physiol; 1977 Feb; 90(2):361-47. PubMed ID: 65357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents.
    Berger B; Marquardt H; Westendorf J
    Cancer Res; 1996 May; 56(9):2094-104. PubMed ID: 8616856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.